Read More Earnings Guidance News Top Stories Verizon Misses Q1 Revenue Expectations, FY23 EPS Outlook Lags By Anusuya Lahiri April 25, 9:12 AM Verizon Communications Inc (NYSE:VZ) reported a first-quarter FY23 sales decline of 1.9% year-on-year to $32.9 billion, missing the consensus of… VZ
Read More General Health Care News CytoSorbents Reports Outcomes From A Randomized Controlled Trial Using CytoSorb Blood Purification During Heart Transplant, Recently Published In The European Society Of Cardiology Journal, ESC Heart Failure By Benzinga Newsdesk January 17, 8:18 AM Better hemodynamic stability and lower rates of post-operative shock Patients in the CytoSorb group had lower median Vasoactive-Inotropic Scores (27.2 [14.6–47.7] vs. 41.9 [22.4–63.2], p=0.046) and CTSO
Read More Analyst Ratings News Upgrades Janney Montgomery Scott Upgrades EPR Props to Buy By Benzinga Newsdesk July 7, 6:39 AM Janney Montgomery Scott analyst Robert Stevenson upgrades EPR Props (NYSE:EPR) from Neutral to Buy. EPR
Read More Analyst Ratings News Price Target Mizuho Maintains Neutral on American Assets Trust, Lowers Price Target to $30 By Benzinga Newsdesk July 27, 9:41 AM Mizuho analyst Haendel St. Juste maintains American Assets Trust (NYSE:AAT) with a Neutral and lowers the price target from $37 to $30. AAT